Aubagio Uniunea Europeană - română - EMA (European Medicines Agency)

aubagio

sanofi winthrop industrie - teriflunomidă - scleroză multiplă - imunosupresoare selective - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

AUBAGIO România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

aubagio

opella healthcare international sas - franta - teriflunomidum - compr. film. - 14mg - imunosupresoare imunosupresoare selective

AUBAGIO România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

aubagio

opella healthcare international sas - franta - teriflunomidum - compr. film. - 7mg - imunosupresoare imunosupresoare selective